In situ hybridisation

In situ hybridisation (ISH) is an extremely powerful research tool for the molecular biologist, which allows cellular localisation of a variety of nucleic acid sequences. With the development of novel techniques such as differential display PCR, subtractive hybridisation and transgenic animal technology, there is a much increased need for the cellular localisation of genes isolated or expressed using these techniques. Many of the pharmaceutical companies are also currently compiling information regarding novel genes with potential therapeutic implications. There will be an increasing need to localise these genes and examine the effects of therapeutic agents on gene transcription, which can be done using ISH.

Taking the hassle out of In situ hybridisation

We offer a complete In situ hybridisation (ISH) service which can be tailored to your specific requirements. Orion can save you money and allow your organisation to concentrate on it's core capabilities. By contracting out your ISH needs to the us you negate the need to spend time and money building up your own 'expertise' in what is, probably, not core to your business. Furthermore, you will find that Orion offers the best value, tailored ISH service in the market.

Our service does not end once our comprehensive report reaches you. We are contactable before, during and after completion of your project in order to answer any questions you may have. We understand that no two organisations will have exactly the same requirements which is why we also customise our service to suit any of your individual needs.

Services